Wake up, breakfast, morning workout with mobility work and hitting baseballs, work at Personal Pitcher, a company that makes ...

Ad hoc announcement pursuant to Art. 53 LR BV100 is a potential best-in-class anti-infective agent in treating hospital-acquired bacterial ...

BioVersys receives US FDA nod to recruit US patients for BV100 HABP/VABP phase 3 trial to treat hospital-acquired or ventilator-associated bacterial pneumonia: Basel, Switzerland ...

Mr. Birla on Sunday (March 15, 2026) expressed “deep concern” over showing of banners, placards, posters and use of certain language inside the House by some MPs and urged leaders of all political ...

From cholera surges to Disease X fears, a new report maps the pressures straining fragile health systems worldwide ...

The ex-lawyer started his firm about a decade ago after getting a taste for residential real estate development in New York.

In a proof-of-concept study, researchers tested a novel approach to mitigate deadly bat-borne viruses from jumping into ...

In a new study, bats lap up vaccine-laced saline or chow down on vaccine-carrying mosquitoes. Will that have any impact on the flying mammal's immune system?

Bats are reservoirs for several zoonotic viruses, such as Ebola and coronaviruses. These pathogens can spread to humans ...

A unique infectious disease containment strategy has emerged that uses mosquitoes to spread vaccines to bats. The method ...

Before Yersinia pestis devastated Europe in the Middle Ages, the bacteria ravaged the Bronze Age for nearly two millennia.